SB

Satheesh Babu Kotla

Active Director Director DIN 10940991
DIN 10940991 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Satheesh Babu Kotla

Data last updated:

Satheesh Babu Kotla is a Director at Glovet Life Sciences Private Limited (since 2025). The company operates in Healthcare.

DIN 10940991
Primary Designation Director
Industry Healthcare
First Appointment 06 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glovet Life Sciences Private Limited U47721TS2025PTC193774
Director06 Feb 20252025Active

Board colleagues of Satheesh Babu Kotla

Directorship timeline

Open interactive timeline →
Glovet Life Sciences Private Limited
Premium access

Shareholding and investment profile for Satheesh Babu Kotla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satheesh Babu Kotla

Satheesh Babu Kotla currently holds 1 directorship: Glovet Life Sciences Private Limited (Director, since 06 Feb 2025).

Satheesh Babu Kotla was first appointed on 06 Feb 2025 as Director at Glovet Life Sciences Private Limited.

The current boards of Satheesh Babu Kotla's companies include Chandra Sekhar Korrapati (Glovet Life Sciences Private Limited), Subhashini Puligadda (Glovet Life Sciences Private Limited), Vijay Kumar Cingeetam (Glovet Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available